Management of Crohn's Disease in Poor Responders to Adalimumab

Clinical and Experimental Gastroenterology - New Zealand
doi 10.2147/ceg.s47627
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Pediatric Crohn's Disease: Epidemiology and Emerging Treatment Options

Pediatric Health, Medicine and Therapeutics
2014English

The Role of Laboratory Tests in Crohn’s Disease

Clinical Medicine Insights: Gastroenterology
Gastroenterology
2016English

Epigenetic Mechanisms in Alzheimer's Disease

Degenerative Neurological and Neuromuscular Disease
2014English

Anal Canal Cancer Associated With Crohn' S Disease

Nippon Daicho Komonbyo Gakkai Zasshi
2003English

Ovarian Stimulation Modalities in Poor Responders

Turkish Journal of Medical Sciences
Medicine
2019English

Peripheral Neutrophil Functions and Cell Signalling in Crohn`s Disease

PLoS ONE
Multidisciplinary
2013English

Proteinopathy, Oxidative Stress and Mitochondrial Dysfunction: Cross Talk in Alzheimer's Disease and Parkinson's Disease

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Brain Perfusion in Fibromyalgia Patients and Its Differences Between Responders and Poor Responders to Gabapentin

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2012English

Endoscopic Balloon Dilation for Ileal Stricture in Crohn^|^apos;s Disease

Progress of Digestive Endoscopy
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy